We cover: Why chasing healthcare superintelligence misses the point How Color uses AI to speed up care and not take over decision-making Their pivot from genetic testing to full-scale clinical delivery How they cut time to treatment in half and boosted screening by 70% Partnering with OpenAI, Memorial Sloan Kettering, and major employers Tune in wherever you listen to podcasts
Wilding JPH, Batterham RL, Calanna S, Davies M, Gaal LFV, Lingvay I, et al
Are there safer, cheaper, natural alternatives to boost GLP-1 with diet and lifestyle
Analysts forecast that the obesity drug market will be worth $100 billion by 2030
Preclinical studies in diet-induced obesity rodent models are ongoing to evaluate its efficacy, safety, and tolerability as a potential therapy for type 2 diabetes and obesity